Imunon (IMNN) Earnings Date & Reports

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the bodyâ€™s natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

IMNN is expected to report earnings to rise 43.00% to -35 cents per share on May 19

Q1'25

Est.

$-0.36

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.05

The last earnings report on February 27 showed earnings per share of -25 cents, beating the estimate of -36 cents. With 76.04K shares outstanding, the current market capitalization sits at 14.62M.

View a ticker or compare two or three

Compare

IMNN